Barry Borlaug, MD
Advanced Heart Failure and Transplant Cardiology · Rochester, MNNPI 1518975374
Payments from drug & device makers
Across 313 payments — averaging $6222.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1.2M
- Novo Nordisk$491K
- Novo Nordisk AS$138K
- Eli Lilly$55K
- Merck$29K
- Boehringer Ingelheim International GmbH$25K
- plus $57K from 10 others
Across 7 payments — averaging $2566.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$17K
- Eli Lilly$713
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 27 | $1,152,398 |
| Novo Nordisk | 13 | $491,384 |
| Novo Nordisk AS | 180 | $137,743 |
| Eli Lilly | 47 | $54,525 |
| Merck | 8 | $29,241 |
| Boehringer Ingelheim International GmbH | 12 | $25,009 |
| Sensible Medical Innovations Ltd | 1 | $15,000 |
| Edwards Lifesciences | 9 | $10,934 |
| Janssen Research & Development, LLC | 2 | $10,875 |
| Regeneron | 4 | $4,956 |
| Abbott | 5 | $4,200 |
| Novartis | 1 | $3,960 |
| Amgen | 1 | $2,975 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $2,275 |
| Biotronik Inc. | 1 | $1,600 |
| Bard Peripheral Vascular, Inc. | 1 | $650 |
How this compares
$1,947,725 in reported general payments places this provider in the 95th percentile of 32 advanced heart failure and transplant cardiology providers in Minnesota.
See all advanced heart failure and transplant cardiology providers in Minnesota →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Rochester
- Robert FrantzRochester$1.5M
- Omar AbouezzeddineRochester$659K
- Naveen PereiraRochester$231K
- Margaret RedfieldRochester$218K
- Veronique RogerRochester$66K
- Atta BehfarRochester$18K
- Wayne MillerRochester$15K
- Swaiman SinghRochester$9K
- Dipan UppalRochester$4K
- Farris TimimiRochester$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.